A prospective study on drug utilization pattern & rationality in treatment of type II diabetes mellitus: a population based analysis

Shruti Vihang Brahmbhatt, Bhagya Manoj Sattigeri, Ashok Kumar Nil, Devang Pravinkumar Parikh, Heena Sunilbhai Shah

Abstract


Background: Diabetes a chronic disease is associated with significant morbidity, complications with poor glycemic control. Hence, meticulous management is necessary. Comorbid conditions increase chances of polypharmacy and irrational prescriptions in diabetic patients. This prospective non interventional study aimed to gather and study the drug utilization pattern in diabetic patients.

Methods: The study was conducted in 50 diabetic patients admitted in medicine ward. Patients were included in the study only after obtaining written informed consent form; all relevant data were collected from case record forms and were analyzed.

Results:Diabetes mellitus was observed to be highest in patients with the age group of 60-70 years, affecting 66% males and 34% females. Among the participants 42 (84%) were already on treatment for diabetes while 8 (16%) were diagnosed at the time of admission. We observed that 27 (54%) patients were treated with insulin + oral hypoglycemic agents, 13 (26%) were treated with only Insulin while 10 (20%) patients were prescribed only oral hypoglycemic agents. The most common comorbid conditions observed by us were hypertension, chronic renal disease, diabetic foot, septicemia, urinary tract infections and other susceptible infections.

Conclusion:To conclude, the study reveals that Metformin continues to be the choice of oral hypoglycemic agents with least adverse effects and insulin was used to treat uncontrolled state, where physicians have greatly considered the socio-economic status while prescribing which is obvious with least use of costly insulin preparations.

 


Keywords


Diabetes mellitus, Drug utilization, Insulin, Metformin, Oral hypoglycemic agents

Full Text:

PDF

References


International Diabetes Federation. Diabetes atlas, 2009. Available at: http://www.diabetesatlas.org/content/diabetes. Accessed 7 September 2011.

Sultana G, Kapur P, Aqil M, Alam MS, Pillai KK. Drug utilization of oral hypoglycemic agents in a university teaching hospital in India. J Clin Pharm Ther. 2010;35(3):267-77.

Lisha Jenny John, Mohammed Arifulla, Jayadevan Sreedharan, Jayakumary Muttappallymyalil, Rajdeep Das, Jenny John, et al. Age and gender-based utilization pattern of antidiabetic drugs in Ajman, UAE. Malaysian J Pharmaceut Sci 2012;10(1):79-85.

Guidoni CM, Borges AP, Freitas O, Pereira LR. Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis. Arq Bras Endocrinol Metab. 2012;56:2.

Triplitt CL, Reasner CA, Isley WL. Diabetes mellitus. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathological Approach. 6th ed. New York: McGraw-Hill Inc.; 2005: 1333.

Cantrill JA, Wood J. Diabetes mellitus. In: Walker R, Edwards C, eds. Clinical Pharmacology and Therapeutic. 3rd ed. New York: Churchill Livingstone; 2003: 657-677.

Joshi SR. Management of obese Indian patient. Indian J Obes. 2005;I(1):11-20.

Kumar P, Mallik D, Mukhopadhyay DK, Sinhababu A, Mahapatra BS, Chakrabarti P. Prevalence of diabetes mellitus, impaired fasting glucose, impaired glucose tolerance, and its correlates among police personnel in Bankura district of West Bengal. Indian J Public Health. 2013 Jan-Mar;57(1):24-8.

Nathan DM, Buse JB, Davidson MB, Heine RJ. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabet Care. 2006 Aug;29(8):1963-72.

Upadhyay DK, Palaian S, Ravi Shankar P, Mishra P, Sah AK. Prescribing pattern in diabetic outpatients in a tertiary care teaching hospital in Nepal. J Clin Diag Res. 2007;3:248-55.

Vengurlekar S, Shukla P, Patidar P, Bafna R, Jain S. Prescribing pattern of antidiabetic drugs in Indore city hospital. Indian J Pharmaceut Sci. 2008;70(5):637-40.

Boccuzzi SJ, Wogen J, Fox J, Sung JC, Shah AB, Kim J. Utilization of oral hypoglycemic agents in a drug-insured U.S. Population. Diabet Care. 2004;24(8):1411-5.

Johnson JA, Pohar SL, Secnik K. Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Serv Res. 2006;6:159.

Yurgin N, Secnik K, Lage MJ. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin Ther. 2007;29(2):316-25.

Sutharson L, Hariharan RS, Vamsadhara C. Drug utilization study in diabetology outpatient setting of a tertiary hospital. Indian J Pharmacol. 2003;35:237-40.

National Institute for Clinical Excellence. Management of type 2 diabetes. Management of blood glucose. In: Guideline G1-27. London: National Institute for Clinical Excellence; 2002: 1-30.

Patel B, Oza B, Patel KP, Malhotra SD, Patel VJ. Pattern of antidiabetic drugs use in type-2 diabetic patients in a medicine outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2013 Jul-Aug;2(4):485-91.

R. Ramesh, Subash Vijaya Kumar, S. Gopinath, B. Gavaskar, G. Gandhiji. Diabetic knowledge of rural community and drug utilization pattern in a tertiary care hospital. Int J Pharm Life Sci. 2011;2(1):531-5.

Chiang CW, Chiu HF, Chen CY, Wu HL, Yang CY. Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003. J Clin Pharm Therap. 2006;31:73-82.

Al Khaja KA, Sequeira RP, Mathur VS. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain. Ann Pharmacother 2001;35(11):1350-9.

Yki-Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Intern Med. 1999;130:389-96.

Strowig S, Aviles-Santa ML, Raskin P. Improved glycemic control without weight gain using triple therapy in type 2 diabetes. Diabet Care. 2004;27:1577-83.

Fonseca V, Rosenstock J, Patwardhan R, Salzman A. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus. J Am Med Assoc. 2000;283:1695-702.

Bailey CJ, Bagdonas A, Rubes J, McMorn SO, Donaldson J, Biswas N, et al. Rosiglitazone/metformin fixed dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24 week, multicenter, randomized, double blind, parallel group study. Clin Ther. 2005;27:1548-61.